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Abstract
Background
Dengue is the most rapidly spreading arboviral disease in the world. The current lack of fully
protective vaccines and clinical therapeutics creates an urgent need to identify more effec-
tive means of controlling Aedes mosquitos, principally Aedes aegypti, as the main vector of
dengue. Pyriproxyfen (PPF) is an increasingly used hormone analogue that prevents juve-
nile Aedes mosquitoes from becoming adults and being incapable of transmitting dengue.
The objectives of the review were to (1) Determine the effect of PPF on endpoints including
percentage inhibition of emergence to adulthood, larval mortality, and resistance ratios; and
(2) Determine the different uses, strengths, and limitations of PPF in control of Aedes. A sys-
tematic search was applied to Pubmed, EMBASE, Web of Science, LILACS, Global Health,
and the Cochrane database of Systematic Reviews. Out of 1,369 records, 90 studies met
the inclusion criteria. Nearly all fit in one of the following four categories 1) Efficacy of gran-
ules, 2) Auto-dissemination/horizontal transfer, 3) use of ultra-low volume thermal fogging
(ULV), thermal fogging (TF), or fumigant technologies, and 4) assessing mosquito resis-
tance. PPF granules had consistently efficacious results of 90–100% inhibition of emer-
gence for up to 90 days. The evidence is less robust but promising regarding PPF dust for
auto-dissemination and the use of PPF in ULV, TF and fumigants. Several studies also
found that while mosquito populations were still susceptible to PPF, the lethal concentra-
tions increased among temephos-resistant mosquitoes compared to reference strains.
The evidence is strong that PPF does increase immature mortality and adult inhibition in set-
tings represented in the included studies, however future research should focus on areas
where there is less evidence (e.g. auto-dissemination, sprays) and new use cases for PPF.
A better understanding of the biological mechanisms of cross-resistance between PPF,
temephos, and other insecticides will allow control programs to make better informed
decisions.
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Author summary
Many important diseases are spread by Aedes mosquitoes including dengue, chikungunya,
Zika, and yellow fever. Dengue cases are increasing worldwide and there is a lack of effec-
tive vaccines and therapeutics. Additionally, mosquitoes have become resistant to com-
monly used insecticides. Pyriproxyfen (PPF) is an insecticide that prevents juvenile Aedes
mosquitoes from becoming adults. The objective of this review was to determine the effect
of PFF on percentage inhibition of emergence to adulthood, larval mortality, and resis-
tance ratios and determine different use cases, strengths, and limitations. A systematic
search was applied to scholarly databases where 67 full text articles met the inclusion crite-
ria. Nearly all included studies fit in four categories, 1) granules, 2) auto-dissemination, 3)
ultra-low volume spray, thermal fogging, and fumigant formulations, and 4) mosquito
resistance. While mosquito populations were still susceptible to PPF, the concentrations
needed to kill a majority of mosquitoes increased among those resistant to temephos (a
commonly used insecticide). The evidence is strong that PPF granules do increase imma-
ture mortality and adult inhibition, however evidence for other forms and uses is still
weak or could be increased. Better understanding of the cross-resistance between PPF,
temephos, and other insecticides will allow control teams to make better informed
decisions.
Introduction
Dengue is transmitted through bites of infected Aedes mosquitoes, principally Aedes aegypti
[1]. Although dengue virus infection in humans is clinically apparent in only approximately
25% of cases, it can lead to wide range of clinical manifestations from mild fever to potentially
fatal shock syndrome [1]. Despite current research devoted to drug discovery and supportive
treatments there is currently no effective antiviral cure for dengue and therefore treatment
remains supportive [2]. Dengue infections are caused by four closely related viruses named
DEN-1, DEN-2, DEN-3, and DEN-4. Research suggests lifelong immunity is developed after
infection but is type-specific [3]. The occurrence of severe symptoms is frequently associated
with a secondary infection of a different serotype [1].
Approximately 3.9 billion people in 128 countries are at risk of dengue infection [4]. The
disease affects most of the world’s tropical and sub-tropical regions and has become the most
rapidly spreading mosquito-borne viral disease [1,5]. There were an estimated 390 million
infections in 2010, of which 96 million were clinically apparent [4]. These estimates are based
on data from various sources including published literature, surveillance data, news reports,
and consultations with experts [5]. As the data themselves are of varying quality and complete-
ness the estimates have large confidence intervals. However, the estimates do represent a global
consensus of experts that suggests the number of infections is increasing over time and
expanding geographically [4]. Between 2010 and 2020 the World health Organization (WHO)
is aiming to reduce morbidity and mortality from dengue by least 50% and 25%, respectively
[6].
Academics and leading dengue control experts have expressed that regardless of the efficacy
of future vaccines, there is growing consensus that no single intervention will be sufficient to
control dengue disease [7]. Vector control therefore remains a key part of any dengue control
program, and the integration of locally accepted and effective methods is needed [8].These
methods together with the development of new vaccines [9], genetic control of mosquitoes
[10,11], and new therapeutic drugs [2] will be essential in reducing dengue incidence. In
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addition to reducing dengue these vector control methods can also reduce other diseases trans-
mitted by Aedes mosquitoes, principally Aedes aegypti, such as chikungunya, Zika, and yellow
fever [12]. One insecticide that has been increasingly used is pyriproxyfen (PPF). PPF is a hor-
mone analogue that interferes with the metamorphosis of juvenile Aedes mosquitoes, prevent-
ing their development into adults capable of transmitting the dengue virus [13]. A recent
systematic review assessing the community effectiveness of PPF found it is highly effective in
controlling the immature stages of Aedes mosquitoes, and to a smaller degree adult Aedes pop-
ulations [14]. Therefore, in this review we are extending the breadth of the systematic review
by identifying all evidence (including lab and semi-field studies and use in combined or novel
products) on the effect of PPF on Aedes mosquitoes.
Objectives
The objectives of the review were to (1) Determine the effect of PPF on a range of endpoints
including percentage inhibition of emergence, larval mortality, and resistance levels (Table 1);
and (2) Determine the different uses, strengths, and limitations of PPF in vector control of
Aedes.
Methods
Search strategy and eligibility criteria
This review follows the guidelines as laid out in the Preferred Reporting Items for Systematic
Reviews and Meta-Analysis (PRISMA) statement [15] (S1 Table). It was carried out between
July 2016 and October 2016, with an update in March-April 2019. All data were extracted by
two independent researchers, and discrepancies were resolved by consensus. All studies
reporting original data on the use of pyriproxyfen in control of Aedes or Stegomyia as a single
agent or combined with other control measures were eligible for inclusion. Any study not
meeting the inclusion criteria above was excluded.
Data sources and search strategy
Studies were identified by searching electronic databases, scanning reference lists of articles
and consultation with experts in the field. No limits were applied for language in case there
was an available English translation. If no translation was available only English and Spanish
articles were evaluated. The search was applied to Pubmed, EMBASE, Web of Science,
LILACS, Global Health, and the Cochrane Database of Systematic Reviews.
Table 1. Table of outcome measures in included studies.
Outcome measures in included
studies
Definition
% Larval Mortality The number of larvae that die/number of larvae included in the experiment
% Inhibition of Emergence The number of mosquitoes that emerge as adults/number of mosquitoes
included in the experiment
Egg Density Index The number of eggs/numbers of positive traps
Breteau Index The number of positive containers per 100 houses inspected.
Pupal Mortality The number of pupae that die/The number of pupae included in the experiment
Post treatment adult rate ratio The number of adults collected before the treatment/the number of adults
collected after the experiment
adult mosquito abundance The number of adult mosquitos per unit (e.g. house, premise)
https://doi.org/10.1371/journal.pntd.0008205.t001
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The International Commission on Zoological Nomenclature (ICZN) which governs the
nomenclature aspects of zoological taxonomy changed the name of the genus Aedes to Stego-
myia [16]. However, here we follow the suggestion of the American Journal of Tropical Medi-
cine and Hygiene, made in consultation with several other journals [17], to continue to use
Aedes as the genus name. Nevertheless, we have also searched based on Stegomyia. The search
terms in Table 2 were applied to all databases.
Study selection
For each search, titles and abstracts were imported into Endnote (Thompson Reuters, Phila-
delphia, PA, USA), duplicates were removed, and the remaining records were screened. Full
texts of potentially relevant records were retrieved and assessed for eligibility, contacting the
author of the report as necessary. Reference lists of all potentially eligible articles and reviews
were also searched.
A data extraction sheet was developed, and pilot tested on a random selection of included
studies and refined accordingly. As many of the studies were not directly comparable (e.g. due
to different concentrations, formulations, or combinations of insecticides) a meta-analysis was
not attempted. The review protocol was registered with the International Prospective Register
of Systematic Reviews (CRD42016046772). The data extraction sheet was used to enter rele-
vant information on each of the included studies, and the resulting tables were used to analyse
the effect of PPF. Additional relevant information from each of the studies was entered in a
comment section of the extraction sheet for further analysis when writing the manuscript.
Results
Search results
The search results are illustrated in S1 Fig. Initially 1,409 records were identified through data-
base searches and 17 additional records were identified through other sources. After screening
of title and abstracts, the remaining 109 papers were assessed and reviewed in full, after which
18 articles were excluded. “The most common reasons for exclusion among the full text articles
were that papers on PFF reported non-original data, e.g. reviews or perspective pieces (n = 10),
or PPF was only tangentially mentioned (again with no relevant original data, n = 8).” A total
of 91 studies were then included in the review (S1 Fig).
Study characteristics
The included studies were published between 1989 and 2018. Six studies were written in Span-
ish, and the others in English. The studies came from many regions including South America
(30%), North America (28%), Asia (17%), Europe (9%), Caribbean (17%), Middle east (5%),
Table 2. Search Terms Used for Systematic Review.
Pyriproxyfen AND Mosquito Control [MESH]
Pyriproxyfen AND Insect Control [MESH]
Pyriproxyfen AND Insect Vectors [MESH]
Pyriproxyfen AND Disease Vectors [MESH]
Pyriproxyfen AND Communicable Disease Control [MESH]
Pyriproxyfen AND Dengue
Pyriproxyfen AND Aedes
Pyriproxyfen AND Stegomyia
(autodissemination of pyriproxyfen) AND Aedes
https://doi.org/10.1371/journal.pntd.0008205.t002
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and Australia (3%). Out of all the 91 studies included, 72 (79.1%) were related to one of the fol-
lowing four core topics and one was related to two of the core topics:
• Efficacy of PPF granules (30 studies) [18–47];
• Auto-dissemination or horizontal transfer of PPF (19 studies) [39,48–66];
• Use of PPF ultra low volume, thermal fogging, and fumigant technologies (15 studies) [67–
80];
• Assessing resistance of Aedes mosquitoes to PPF (10 studies) [81–90].
Other less common topics were: the use of PPF in novel products (bed nets [65,91], paints
[92], release blocks [93], sugar baits [94,95], candles [96], topical treatments [97–99] ovitraps
[100,101], resin sticks [102–104], and controlled release mesh [105]; the effect of PPF on the
termination of the diapause process [106]; and PPF’s environmental persistence and effect on
non-target organisms [107]. There was also a review written in 2008 by a PPF manufacturer
that focused on the different uses for PPF as a larvicide against nuisance mosquitoes and vec-
tors of dengue and malaria [108].
Efficacy of PPF granules
PPF granules have been shown to be efficacious in a wide range of lab and field tests in coun-
tries across the world. Despite some discrepancies, most studies showed Inhibition of Emer-
gence (IE) near 100% for 90 days at higher concentrations (1–10 parts-per-million (ppm)),
and a steady reduction with time post-treatment or with decreasing concentration of active
ingredient (Fig 1). Vythilingam et al. found that adult emergence was completely inhibited for
four months even with removal and addition of water [32]. However, Richie et al. found that
residual PPF detected in water one week later represented just 1.2–1.4% of the total doses
applied regardless of the concentration, and the authors highlighted the need to integrate the
quick deterioration into any concentration planned for vector management programs [25].
Berti et al. found that increasing the number of larvae treated at 0.05 ppm did not decrease
mortality of pupae or adult IE [41].
Studies also suggested that the use of PPF as an alternative to other commonly used insecti-
cides such as temephos or in an integrated method with other means of mosquito control will
increase the efficacy with subsequent reduction in the development of resistance [44,83]. Dar-
riet et al. [42] showed the synergetic effect of the rapid killing of mosquito larvae by spinosad
(an insecticide based on compounds found in the bacterial species Saccharopolyspora spinosa)
along with the ability of PPF to kill any pupae that emerged in their trial. Using PPF in combi-
nation with other vector control tools (Aquatain AMF or larvicidal oil) was also suggested for
emergency control programs [33]. Even using very low doses for short periods has been sug-
gested as a strategy to reduce wild populations before the introduction of genetically modified
mosquitoes [25].
Auto-dissemination or horizontal transfer of PPF
Auto-dissemination or horizontal transfer of PPF is the concept that exploits female mosqui-
toes to transfer lethal concentrations of an IGR to breeding or resting sites during oviposition,
resulting in a reduction of mosquito population by juvenile mortality and subsequent recruit-
ment of adults [48–51,59–66]. The possibility was first tested by forcing adult female and male
mosquitoes into contact with PPF coated surfaces in the laboratory [49,60,63]. Studies showed
that auto-dissemination occurred, and it successfully increased the mortality rate of larvae that
were exposed (See Fig 2).
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Devine et al. [61] distributed 1-liter plastic pots lined with damp black cloth dusted with
pulverized PPF granules in the field and achieved overall reductions in adult emergence of 42–
98% thus achieving high coverage of aquatic mosquito habitats. Around the same time, Suman
et al. [51], trialed the ability of mosquitoes to auto-disseminate PPF from Ultra-Low Volume
(ULV) surface treatments in the field and achieved 15.8% pupae mortality from six weeks in
the first year and 1.4% pupae mortality in the second year. ULV spraying is defined as spraying
of pesticides at a volume application rate of less than 5 litres/hectare to provide maximum effi-
cacy in killing target vector mosquitoes. Both authors detected that auto-dissemination
occurred, however ULV applications were determined not suitable for auto-dissemination.
Similar results were found in more recent studies using PPF sprays which found no difference
in sentinel containers between intervention and control areas [56]. Better formulations and
delivery methods that could load higher doses of PPF and last longer were tested in the lab
[59,62] with varying degrees of efficacy.
Fig 1. Summary of 30 studies included investigating the effect of PPF granules.
https://doi.org/10.1371/journal.pntd.0008205.g001
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Abad-Franch et al. used these auto-dissemination stations in a field trial and found greater
than ten-fold rise and greater than a ten-fold decrease in juvenile mosquito mortality and
adult mosquito emergence, respectively [48]. However, many of the field studies lacked assays
sufficiently sensitive to detect the parts-per-billion concentrations of PPF, therefore limiting
the direct evidence of PPF contamination [48]. Although, a recent paper reporting on five dif-
ferent studies done in New Jersey, USA was able to detect PPF by residue analysis in field sam-
ples confirming the transfer of PPF by mosquitoes for up to 200 meters [57]. The study used
auto-dissemination stations in different contexts and environments and found the stations
performed effectively for 8–12 weeks and were able to contaminate 40% of sentinel containers
in tire piles 50% in a junkyard. This resulted in the highest pupal mortality in peri-domestic
habitats (50%), and sites contaminated with PPF 82%, although the efficacy reduced over time
[57].
Fig 2. Summary of 19 studies included investigating the effect of auto dissemination or horizontal transfer of PPF.
https://doi.org/10.1371/journal.pntd.0008205.g002
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Snetselaar et al. [50] found 100% IE with the use of a black polyethylene device (In2Care
mosquito trap) coated with PPF dust and Beauveria bassiana in a semi-field study. B. bassiana
is a fungus that grows in soils throughout the world and infects mosquitoes reducing their vec-
toral capacity, inhibiting dengue virus replication, and eventually killing the mosquito [50]. A
subsequent semi-field study using the product in Florida found the trap to be attractive to
gravid mosquitoes, ability to transfer PPF to sentinel containers, reduce emergence of adult
mosquitoes, and reduce survivorship of adult mosquitoes exposed to B. bassiana [53].
Main et al. evaluated the use of the "Auto-Dissemination Augmented by Males" (ADAM)
approach which used a black plastic device to attract adult females, but also introduces directly
treated males (who were exposed to PPF by an insufflator for approximately 5 sec) to transfer
PPF to both larval sites and uninfected females during oviposition. Results in a field setting
showed 50% reduction in immature mortality rates compared with controls [64]. Field trials
demonstrated the ability of PPF-treated males to transmit lethal doses to introduced oviposi-
tion containers, both in the presence and absence of indigenous females. A decline in the
Aedes albopictus population was observed following the introduction of PPF-treated males,
which was not observed in two untreated field sites [64]. However, the decrease was not as
large as shown by Abad-French et al., which may be due to different environments, susceptibil-
ity of the vectors to PPF, different mosquito targets, or different PPF sources and
concentrations.
The benefit of auto-dissemination is the potential to effectively counter the main challenge
to conventional larviciding approaches by targeting the myriad of cryptic breeding sites that
these mosquitoes utilize [48,59]. However, area-wide use requires large amounts of labor when
deploying and maintaining numerous stations [63]. Lastly, auto-dissemination efficacy can be
affected by several factors such as insecticide resistance, coverage of treated areas, treatment
methods, geographical variations and rainfall [51].
Use of PPF ultra-low volume spray, thermal fogging, and fumigant
technologies
Studies investigating the use of PPF in ULV, thermal fogging (TF) and fumigant techniques
found IE declining from 100%-50% for 4–6 weeks respectively in treated areas and steadily
decreasing with the distance from the sprayer, the length of time from treatment, and type
(cold/thermal) of fogging (Fig 3) [67,68,73–79]. Beyond simply having an effect on larval mor-
tality, the sublethal dose of PPF was found to have effects on the fertility and fecundity of adult
females who were exposed at the adult stage. Therefore, even if the lethal dose is not achieved,
treatment over the long term help decrease the mosquito population through the effects on
their reproductive capabilities [76].
Harburguer et al. suggested a strategy including fumigant tablets placed indoors and mixed
ULV formulation (including permethrin) for outdoor application [73]. The fumigant they
developed showed a high level of recovery of PPF in fumes and resulted in high levels of IE
even at low concentrations, as well as an effective knockdown of adults from the permethrin.
One limitation of the study data presented above was that they treated only a reduced area
(200 houses the same size and evenly spaced and distributed within each of three different
treatment areas) and there could have been infestation from adults in nearby households [73].
More recently, studies in Thailand and the USA have shown that multiple spraying
machines using combinations of insecticides including PPF were unable to achieve high mor-
tality among Aedes mosquitoes placed in hidden (protected) cages, and that the ULV sprays
provided better emergence inhibition than the thermal foggers likely due to larger droplet size
[70–72].
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Assessing resistance and dose-response relationship of Aedes mosquitoes to
PPF
Understanding resistance profiles of juvenile and adult mosquitoes is key in public health con-
trol programs. Numerous papers reviewed the susceptibility of Aedes to PPF and examined
cross resistance among PPF and other insecticides (especially temephos). Data show IE levels
of 70–100% for 250 days among higher concentrations with levels decreasing with lower con-
centrations and extended post-treatment time (Fig 4) [38,81–83,85–87,109].
Even among temephos-resistant mosquito populations IE levels show susceptibility to PPF
at higher concentrations with the exception of a Florida population already resistant to two
other Insect Growth Regulators (IGRs) and dichlorodiphenyltrichloroethane (DDT) [86].
However, their data showed standard larvicides and pyrethroids used for mosquito control
were still effective [86]. Indeed, this is opposite of most other studies reviewed here showing
resistance of Aedes populations to standard larvicides and pyrethroids and susceptibility to
IGRs [81–85,87–90].
Rodriguez Coto et al. [110] and Teran Zavala et al. [87] both showed that temephos-resis-
tant strains had similar resistance ratios to reference strains and worked well even at concen-
trations below World Health Organization (WHO) recommended levels (Resistance Ratio is
the measure of resistance in an insect population, calculated by dividing the lethal dose of a
study population by the lethal dose of the susceptible population) However, three other studies
[83,109,110] found that while mosquito populations were still susceptible to PPF, the lethal
concentrations increased among temephos resistant mosquitoes compared to reference
strains. Marcombe et al. [86] noted that as PPF has never been used in public health programs
Fig 3. Summary of 15 studies included investigating the effect of PPF ultra low volume spray, thermal fogging, and fumigant technologies.
https://doi.org/10.1371/journal.pntd.0008205.g003
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in the United States, it is possible the cross-tolerance of mosquito larvae to IGRs has arisen
through the extensive use of temephos for vector control. Significant differences in detoxifica-
tion enzyme activities in several resistant Aedes albopictus populations in the USA suggests the
involvement of a metabolic based resistance mechanism [86].
Safety
PPF has a very favorable mammalian toxicity profile [49]. Even treatment of drinking water at a
dosage of 0.01 ppm may be used, which is 30,000 times the lethal dose for mosquitoes and six
times the recommended field application rate [32,111,112]. However, as with any chemical there
are still concerns regarding environmental impact of the long-term application of PPF in perma-
nent water bodies highlighting the need for environmental studies supporting such uses [13].
Discussion
The results of this systematic review, which we believe to be the most comprehensive to date,
suggest that PPF can effectively control the emergence of adult Aedes mosquitoes across a wide
variety of environments and in a variety of forms (e.g. granules, ULV sprays, TF, and fumi-
gants). Utilizing a product with a favorable safety profile is especially important in settings
where dose recommendations may not always be followed strictly.
Unsurprisingly, the results show the most common use of PPF in granule form results in
near 100% (IE) for 90 days at higher concentrations even with removal and addition of water
and regardless of the larval density [41]. Integrating PPF with other means of mosquito control
(e.g. spinosad) can increase the efficacy with reduction of the risk of resistance development
[113,114]. Also, the efficacy of PPF may be altered for populations of mosquitoes known to be
resistant to organophosphates (temephos). In areas where the main sources of larval biomass
are identifiable and accessible, such as in rural areas with large water storage jars, controlled
release PPF granules or matrixes could be quite effective.
Fig 4. Summary of 10 studies included investigating resistance of Aedes mosquitoes to PPF.
https://doi.org/10.1371/journal.pntd.0008205.g004
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Although PPF works well in large water containers, other cryptic or subterranean breeding
sites may require significant additional work of control teams to reach. One potential solution
is to utilize auto-dissemination or horizontal transfer of PPF. Evidence shows that auto-dis-
semination occurs, and it successfully increases the mortality rate of larvae that were exposed
while reducing the number and viability of eggs from exposed females. Field trials suggest that
PPF can increase juvenile mosquito mortality and reduce adult mosquito emergence, however
the effect tends to reduce over time, and it is still low enough that additional tools may need to
be used in combination with PPF to reduce Aedes populations to zero (e.g. granules or con-
trolled release devices for key containers). Significant work has been published on this topic
the past two or years illuminating the preferable methods of employment, and the design and
spacing of devices. However, there are still no WHO prequalified auto-dissemination devices
that can be purchased at large scale for control programs to use, even were they to be recom-
mended. Future studies should look further at defining optimum design of devices and stan-
dardized approach for application of PPF dust.
In areas where Aedes breeding is located in large outdoor areas where key containers are
not present or easy to identify, the use of PPF in ULV, TF and fumigants may be appropriate.
Results show IE in treated areas near 100% and steadily decreasing with the distance from the
sprayer, the length of time from treatment, and type (cold/thermal) of fogging. Sublethal doses
of PPF were also found to have effects on the fertility and fecundity of adult females, suggesting
positive effects may reach greater distances away from the sprayer.
Regardless of how effective different PPF products are at distributing the active ingredient,
effectiveness can be reduced or lost if the mosquito develops resistance. The results suggest that
even among temephos-resistant mosquito populations IE levels show susceptibility to PPF at
higher concentrations, with the exception of one Florida population [86]. Many studies found
that while mosquito populations were still susceptible to PPF, the lethal concentrations
increased among temephos-resistant mosquitoes compared to reference strains. This is even
true in areas where PPF has not been used, suggesting the possible cross-tolerance of mosquito
larvae to IGRs has arisen through the extensive use of temephos. Therefore, in areas where there
is already increased resistance to PPF, control programs should consider combining insecticides
that work in synergy. Regular entomological surveillance to monitor the susceptibility status of
Aedes mosquitoes can help provide evidence and prevent development of resistancex [83].
One of the limitations reported is the issue of compliance by community in areas where
top-down government control programs are not distributing PPF [14]. This is due to false per-
ceptions by the community that PPF is ineffective as it mainly acts on late instars and people
may continue to observe live early instar larvae [115]. Qualitative studies are required to better
understand what communication methods and materials would be most effective to increase
community participation in vector control activities.
One of the limitations of this review is the intentionally broad scope and focus on the effect
of PPF on Aedes rather than the community effectiveness of PPF products on the reduction of
dengue. However, a recent review of the community effectiveness of pyriproxyfen as a dengue
vector control method found “community participation and acceptance has not consistently
been successful and needs to be further assessed. While all studies measured entomological
endpoints, only two studies measured the reduction in human dengue cases, with inconclusive
results.”[14] Additionally, another limitation is the lack of meta-analysis as the heterogeneity
of the studies would make the interpretation very difficult and possibly misleading. Hopefully,
more field studies will be done using the same concentrations in the future to allow such a
meta-analysis.
Future studies can focus on further evaluating new PPF products and new use cases for
established products. It will also be important to understand the effectiveness of these products
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in Africa. The majority of studies represented here come from Central/South America and
Asia, and none from India or Africa. However, global estimates suggest Africa’s dengue bur-
den to be equivalent to that of the Americas (16%) and together Africa and India contribute
50% of dengue cases [4]. It will be important to document the effectiveness of these products
in these highly endemic areas [14].
In conclusion, the evidence for the effectiveness of PPF to increase Aedes larval mortality
and IE is strong and consistent. However, the strength of the evidence for different products
and use cases varies considerably. PPF granules have highly documented and consistent results
that suggest it is very effective especially when used in slightly higher doses and distributed
every 30–40 weeks. The use of PPF dust for auto-dissemination and the use of PPF in ULV, TF
and fumigants are encouraging although the evidence in favor of them is not as strong or con-
sistent. Many additional novel products have been evaluated (e.g. bed nets, paints, candles, ovi-
traps), however evidence for these products is very weak at the moment. Future research
should focus on these areas where the evidence is less strong and include additional use cases
that may become developed in the future. Additional research is also needed to elucidate the
biological mechanisms of cross-resistance between PPF, temephos, and other insecticides to
allow control teams to make better informed decisions on which products to recommend and
procure.
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